Canaccord Genuity Keeps Their Buy Rating on Establishment Labs Holdings (ESTA)

In a report released yesterday, Caitlin Cronin from Canaccord Genuity reiterated a Buy rating on Establishment Labs Holdings, with a price target of $60.00. The company’s shares closed yesterday at $44.40.

Elevate Your Investing Strategy:

• Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

According to TipRanks, Cronin is a 3-star analyst with an average return of 3.2% and a 50.91% success rate. Cronin covers the Healthcare sector, focusing on stocks such as Enovis, REPRO-MED Systems, and InMode.

In addition to Canaccord Genuity, Establishment Labs Holdings also received a Buy from TD Cowen’s Josh Jennings in a report issued yesterday. However, on the same day, TR | OpenAI – 4o reiterated a Hold rating on Establishment Labs Holdings (NASDAQ: ESTA).

The company has a one-year high of $50.85 and a one-year low of $26.56. Currently, Establishment Labs Holdings has an average volume of 344.1K.

Based on the recent corporate insider activity of 36 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of ESTA in relation to earlier this year. Most recently, in August 2025, NICHOLAS SHERIDAN LEWIN, a Director at ESTA bought 2,600.00 shares for a total of $98,410.00.